Security software company Darktrace, announced last week that it has closed a US$15 million Series B funding, led by Summit Partners, a global growth equity investor.
According to a media statement, this funding will help the company to meet growing international demand, particularly in the United States and the Asia Pacific. In addition, Darktrace said that it will continue to scale the business and hire more people to expand its technology, cyber analyst and commercial teams worldwide.
Following this announcement, Han Sikkens, a Managing Director at Summit Partners and Vanessa Colomar, Partner at Invoke Capital, have joined the Darktrace Board of Directors.
"Summit Partners has decades of experience in supporting exceptional new technologies and highly-skilled teams. We have been impressed by Darktrace's outstanding leadership team and unique combination of security intelligence, technical and commercial skills. We welcome the opportunity to help accelerate the company's growth across the world," said Hikkens.
Led by CEO Nicole Eagan, Darktrace's core Enterprise Immune System technology represents a new class of cyber defense software that helps enterprises and government bodies to protect themselves against advanced attacks and data compromises from within the network. Powered by mathematics and machine learning, the platform analyses network activity and learns the behavior of every device, user and network within an organisation in order to detect abnormal threat behaviors as they emerge.
Sign up for CIO Asia eNewsletters.